• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: W.L. GORE & ASSOCIATES GORE® EXCLUDER® AAA ENDOPROSTHESIS; SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

W.L. GORE & ASSOCIATES GORE® EXCLUDER® AAA ENDOPROSTHESIS; SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT Back to Search Results
Catalog Number RLT311417
Device Problem Collapse (1099)
Patient Problem Not Applicable (3189)
Event Date 07/18/2017
Event Type  Injury  
Manufacturer Narrative
Lot 16372754: udi (b)(4).(b)(4).The review of the manufacturing paperwork verified that this lot met all pre-release specifications.Refer to field for the results of the imaging evaluation.
 
Event Description
On (b)(6) 2017, the patient underwent endovascular repair of an infrarenal abdominal aortic aneurysm and iliac aneurysm with gore® excluder® aaa endoprostheses and a gore® excluder® iliac branch endoprosthesis.It was reported, pre-operative imaging identified extremely tortuous bilateral iliac arteries and an ¿s curve shaped¿ abdominal aorta.According to the report, the procedure concluded without any reported adverse events and final angiography showed exclusion of the aneurysms with patency of all devices.On (b)(6) 2017, follow-up imaging identified device lumen narrowing/compression of the ipsilateral limb implanted on the patient¿s left side.No evidence of thrombus within the device was identified and the limb was reported to be patent without evidence of occlusion.The cause of the device compression is reportedly unknown, however it was reported the compression is believed to be caused by the patient¿s tortuous anatomy.As the patient is reported to be asymptomatic and all devices are reported to be patent, an intervention to treat the compression has not been scheduled.According to the report, the physician will continue to monitor the patient.
 
Manufacturer Narrative
(b)(4).Added patient medications - acetaminophen, aspirin, atorvastatin, cartia xt, eliquis, famotidine, finasteride, furosemide, isosorbide mononitrate, loratadine, oxycodone, potassium chloride.Corrected office contact information.Corrected type of reportable event.Conclusion code remains unchanged.
 
Event Description
On (b)(6) 2017, the patient underwent endovascular repair of an infrarenal abdominal aortic aneurysm and iliac aneurysm with gore® excluder® aaa endoprostheses and a gore® excluder® iliac branch endoprosthesis.It was reported pre-operative imaging identified extremely tortuous bilateral iliac arteries and an ¿s curve shaped¿ abdominal aorta.According to the report, the procedure concluded without any reported adverse events and final angiography showed exclusion of the aneurysms with patency of all devices.On (b)(6) 2017, follow-up imaging identified device lumen narrowing of the trunk ipsilateral limb implanted on the patient¿s left side.No evidence of thrombus within the device was identified, and the limb was reported to be patent without evidence of occlusion.On (b)(6) 2017, an additional procedure was performed as a preventative measure to treat the device narrowing of the (b)(4) ipsilateral limb.The patient has reportedly remained asymptomatic from the narrowing with no evidence of occlusion or outflow issues.It was reported the narrowing of the ipsilateral limb was noted at the aortic bifurcation.It was also reported the device lacked complete wall apposition at the proximal left common iliac artery with no report of endoleak.During the (b)(6) 2017 procedure, two gore® viabahn® vbx balloon expandable endoprostheses were implanted in order to obtain complete device expansion in both areas.Final imaging reportedly showed good expansion of the devices, and the patient tolerated the procedure.According to the additional information received, the narrowing was noted directly after deployment of the trunk on (b)(6) 2017.Additionally, it was reported the ipsilateral limb was implanted in an extremely tortuous areas of the left common iliac artery, and the tortuosity of the iliac artery caused the narrowing of the ipsilateral limb.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
GORE® EXCLUDER® AAA ENDOPROSTHESIS
Type of Device
SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT
Manufacturer (Section D)
W.L. GORE & ASSOCIATES
flagstaff AZ
Manufacturer (Section G)
MEDICAL PHOENIX 2 B/P
32470 n. north valley parkway
phoenix AZ 85085
Manufacturer Contact
claire west
1500 n. 4th street
flagstaff, AZ 
9285263030
MDR Report Key6883891
MDR Text Key87353322
Report Number3007284313-2017-00228
Device Sequence Number1
Product Code MIH
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
P020004
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative
Reporter Occupation Physician
Type of Report Initial,Followup
Report Date 12/19/2017
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date06/05/2020
Device Catalogue NumberRLT311417
Device Lot Number16372754
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received Not provided
Initial Date FDA Received09/21/2017
Supplement Dates Manufacturer ReceivedNot provided
Supplement Dates FDA Received01/11/2018
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured06/06/2017
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Hospitalization; Required Intervention;
Patient Age82 YR
Patient Weight200
-
-